Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan L Uprichard

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
Journal of Virology|February 21, 2014
Determining the involvement and therapeutic implications of host cellular factors in hepatitis C virus cell-to-cell spreadNaina Barretto, Bruno Sainz, Snawar Hussain, et al.
Hepatic Medicine : Evidence and Research|February 19, 2011
Potential treatment options and future research to increase hepatitis C virus treatment response rateVeronica Tencate, Bruno Sainz, Scott J Cotler, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 11, 2005
Clearance of hepatitis B virus from the liver of transgenic mice by short hairpin RNAsSusan L Uprichard, Bryan Boyd, Alana Althage, et al.
Journal of Virology|April 17, 2009
Modeling subgenomic hepatitis C virus RNA kinetics during treatment with alpha interferonHarel Dahari, Bruno Sainz, Alan S Perelson, et al.
Virology Journal|March 22, 2008
Dissecting the role of putative CD81 binding regions of E2 in mediating HCV entry: putative CD81 binding region 1 is not involved in CD81 bindingKatharina B Rothwangl, Balaji Manicassamy, Susan L Uprichard, et al.
Virology Journal|October 31, 2006
Replication of a hepatitis C virus replicon clone in mouse cellsSusan L Uprichard, Josan Chung, Francis V Chisari, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 29, 2003
Transcriptional and posttranscriptional control of hepatitis B virus gene expressionSusan L Uprichard, Stefan F Wieland, Alana Althage, et al.
Antimicrobial Agents and Chemotherapy|September 6, 2012
Identification of hepatitis C virus inhibitors targeting different aspects of infection using a cell-based assayXuemei Yu, Bruno Sainz, Pavel A Petukhov, et al.
Viruses|April 21, 2018
Accounting for Space—Quantification of Cell-To-Cell Transmission Kinetics Using Virus Dynamics ModelsPeter Kumberger, Karina Durso-Cain, Susan L Uprichard, et al.
Virology Journal|January 26, 2012
Permissiveness of human hepatoma cell lines for HCV infectionBruno Sainz, Naina Barretto, Xuemei Yu, et al.
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Journal of Virology|February 21, 2014
Determining the involvement and therapeutic implications of host cellular factors in hepatitis C virus cell-to-cell spreadNaina Barretto, Bruno Sainz, Snawar Hussain, et al.
Hepatic Medicine : Evidence and Research|February 19, 2011
Potential treatment options and future research to increase hepatitis C virus treatment response rateVeronica Tencate, Bruno Sainz, Scott J Cotler, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 11, 2005
Clearance of hepatitis B virus from the liver of transgenic mice by short hairpin RNAsSusan L Uprichard, Bryan Boyd, Alana Althage, et al.
Journal of Virology|April 17, 2009
Modeling subgenomic hepatitis C virus RNA kinetics during treatment with alpha interferonHarel Dahari, Bruno Sainz, Alan S Perelson, et al.
Virology Journal|March 22, 2008
Dissecting the role of putative CD81 binding regions of E2 in mediating HCV entry: putative CD81 binding region 1 is not involved in CD81 bindingKatharina B Rothwangl, Balaji Manicassamy, Susan L Uprichard, et al.
Virology Journal|October 31, 2006
Replication of a hepatitis C virus replicon clone in mouse cellsSusan L Uprichard, Josan Chung, Francis V Chisari, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 29, 2003
Transcriptional and posttranscriptional control of hepatitis B virus gene expressionSusan L Uprichard, Stefan F Wieland, Alana Althage, et al.
Antimicrobial Agents and Chemotherapy|September 6, 2012
Identification of hepatitis C virus inhibitors targeting different aspects of infection using a cell-based assayXuemei Yu, Bruno Sainz, Pavel A Petukhov, et al.
Viruses|April 21, 2018
Accounting for Space—Quantification of Cell-To-Cell Transmission Kinetics Using Virus Dynamics ModelsPeter Kumberger, Karina Durso-Cain, Susan L Uprichard, et al.
Virology Journal|January 26, 2012
Permissiveness of human hepatoma cell lines for HCV infectionBruno Sainz, Naina Barretto, Xuemei Yu, et al.
Pageof 6